2015
DOI: 10.1111/ajd.12307
|View full text |Cite
|
Sign up to set email alerts
|

Cutaneous manifestations of peripheral T‐cell lymphoma, not otherwise specified: A case series highlighting the diagnostic challenges for this heterogeneous group

Abstract: Peripheral T-cell lymphoma, not otherwise specified (PTCL, NOS) is a rare, heterogeneous group of nodal and extranodal mature T-cell lymphomas that do not correspond to any of the defined T-cell entities, according to the World Health Organization classification. Most cases present with late stage nodal disease; however extranodal involvement is common. Skin and subcutaneous involvement is reported in approximately 20% of cases. Little attention has been given to the highly variable skin manifestations in the … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

1
11
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 10 publications
(12 citation statements)
references
References 10 publications
1
11
0
Order By: Relevance
“…3,4,7 Global median OS and PFS (27 and 16.5 months, respectively) corroborate the concept that PC-PTCL-NOS patients overall have a bad clinical outcome notwithstanding the aggressive therapeutic regimens. 3,4 Indeed, the observed OS is quite different to that recently described by Tolkachjow et al 7 : 27 vs. 69 months. As previously reported, the disease has a male predilection (M:F ratio 3:1).…”
Section: Primary Cutaneous Peripheral T-cell Lymphoma Not Otherwise Ssupporting
confidence: 70%
See 1 more Smart Citation
“…3,4,7 Global median OS and PFS (27 and 16.5 months, respectively) corroborate the concept that PC-PTCL-NOS patients overall have a bad clinical outcome notwithstanding the aggressive therapeutic regimens. 3,4 Indeed, the observed OS is quite different to that recently described by Tolkachjow et al 7 : 27 vs. 69 months. As previously reported, the disease has a male predilection (M:F ratio 3:1).…”
Section: Primary Cutaneous Peripheral T-cell Lymphoma Not Otherwise Ssupporting
confidence: 70%
“…[4][5][6] PTCLs-NOS featuring skin lesions present at least six months before a hypothetical systemic involvement are regarded as a separate entity, named primary cutaneous PTCLs-NOS (PC-PTCLs-NOS). 3,4,7 Owing to the fact that an increasing number of cutaneous T-cell lymphoma (CTCL) other than mycosis fungoides (MF) has been recognized in recent years, 2,8 the prevalence of PC-PTCL-NOS cases has significantly decreased. In the present study, all PC-PTCL-NOS cases of the last ten years were retrospectively analysed.…”
Section: Primary Cutaneous Peripheral T-cell Lymphoma Not Otherwise Smentioning
confidence: 99%
“…Other investigators have noted that the diagnosis can be challenging because a dense inflammatory infiltrate may surround tumor cells, malignant T cells may have mild cytologic atypia, and PTCL cells lack a pathognomonic T-cell immunophenotype (typically CD3 + and CD4 + , but many immunophenotypes occur). 2 , 7 …”
Section: Discussionmentioning
confidence: 99%
“…Skin and subcutaneous tissues are involved in more than 20% of the cases, which might appear as a primary cutaneous disease (pcPTCL-NOS) or as a part of systemic lymphoma (sPTCL-NOS) [ 8 ]. Other common extranodal sites are bone marrow, liver, spleen, lungs, and gastrointestinal tract [ 7 9 ].…”
Section: Discussionmentioning
confidence: 99%